Skip to main content
Herbert Meltzer, MD, Psychiatry, Chicago, IL, Northwestern Memorial Hospital

HerbertMeltzerMD

Psychiatry Chicago, IL

Pain Medicine, Psychopharmacology

Professor in Psychiatry and Behavioral Sciences and Physiology, Northwestern University Medical School

Dr. Meltzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Meltzer's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1964 - 1966
  • Icahn School of Medicine at Mount Sinai (Morningside)
    Icahn School of Medicine at Mount Sinai (Morningside)Internship, Transitional Year, 1963 - 1964
  • Yale School of Medicine
    Yale School of MedicineClass of 1963

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1968 - 2026
  • TN State Medical License
    TN State Medical License 1996 - 2013
  • OH State Medical License
    OH State Medical License 1985 - 1998
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • TPA-023 Attenuates Subchronic Phencyclidine-Induced Declarative and Reversal Learning Deficits via GABAA Receptor Agonist Mechanism: Possible Therapeutic Target for Co...  
    Herbert Meltzer, MD, Nature

Press Mentions

  • Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties
    Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health SpecialtiesMay 2nd, 2022
  • Allergan Receives FDA Approval for Use of VRAYLAR™ (Cariprazine) in the Maintenance Treatment of Schizophrenia
    Allergan Receives FDA Approval for Use of VRAYLAR™ (Cariprazine) in the Maintenance Treatment of SchizophreniaNovember 13th, 2017
  • FDA Approves Cariprazine for Schizophrenia Maintenance
    FDA Approves Cariprazine for Schizophrenia MaintenanceNovember 13th, 2017
  • Join now to see all

Grant Support

  • Metabolites Of Neurotransmitters And Stress Hormones In SchizophreniaNational Center For Research Resources2000–2002
  • Cyproheptadine On Cimetidine Induced Prolactin In SchizoNational Center For Research Resources2000–2002
  • Ipsapirone On Plasma Cortisol, Prolactin &Growth Hormone In Psychiatric IllnessNational Center For Research Resources1998–1999
  • Pramipexole In The Treatment Of Tardive DyskinesiaNational Center For Research Resources1995–1996
  • Ipsapirone On Plasma Cortisol, Prolactin, And GH Responses In PsychosisNational Center For Research Resources1994–1996
  • Effect Of Cimetidine On Prolactin SecretionNational Center For Research Resources1994–1996
  • Biological And Clinical Assessment Of DepressionNational Center For Research Resources1994–1996
  • Long-Term Follow-Up Of Treatment-Resistant Patients Treated With ClozapineNational Institute Of Mental Health1992–1996
  • Effect Of Trazodone To Potentiate Imipramine In The Treatment Of DepressionNational Institute Of Mental Health1992–1996
  • Core--PsychopharmacologyNational Institute Of Mental Health1992–1996
  • Core--Neuroendocrinology And PhysiologyNational Institute Of Mental Health1992–1996
  • Comparison Of Two Doses Of Melperone In The Treatment Of SchizophreniaNational Institute Of Mental Health1992–1996
  • Antipsychotic Drug Effects On Plasma HVA And 5-HIAA In Schizophrenia PatientsNational Institute Of Mental Health1992–1996
  • Ipsapirone On Plasma Cortisol, Prolactin, And GH Responses In PsychosisNational Center For Research Resources1992–1996
  • Biological And Clinical Assessment Of DepressionNational Center For Research Resources1992–1996
  • Effect Of Cimetidine On Prolactin SecretionNational Center For Research Resources1990–1996
  • Clinical Utility And Molecular Basis Of Dexamethasone Suppression TestNational Center For Research Resources1995
  • Major PsychosesNational Institute Of Mental Health1994–1995
  • MK-212 On Serum Cortisol, Prolactin And Growth HormoneNational Center For Research Resources1994–1995
  • M-Chlorophenylpiperazine (MCPP) On Cortisol And Prolactin SecretionNational Center For Research Resources1994–1995
  • Apomorphine On Serum Growth Hormone In Psychiatric PTS And Normal VolunteersNational Center For Research Resources1994–1995
  • Biological Studies Of The Major PsychosesNational Institute Of Mental Health1994
  • Sleep Associated Growth Hormone (GH) Changes In Schizophrenic PatientsNational Center For Research Resources1994
  • Neuroendocrine And Biogenic Amine Response To Fenfluramine Or PlaceboNational Center For Research Resources1994
  • Ipsapirone On Plasma Cortisol, Prolactin And GH Responses In Psychiatric IllnessNational Center For Research Resources1993
  • Buspirone On Plasma Cortisol, Prolactin And GH Responses In Psychiatric PatientsNational Center For Research Resources1993
  • Biological And Clinical AssessmentNational Center For Research Resources1993
  • 5-Htp--Pituitary Hormone And Cortisol Secretion In Psychiatric And Control SubjecNational Center For Research Resources1993
  • Sleep Associated Growth Hormone (GH) Changes In Schizophrenic PatientsNational Center For Research Resources1992–1993
  • M-Chlorophenylpiperazine (MCPP) On Cortisol And Prolactin SecretionNational Center For Research Resources1992–1993
  • Buspirone On Plasma Cortisol, Prolactin And Growth Hormone ResponsesNational Center For Research Resources1992–1993
  • Neuroendocrine And Biogenic Amine Response To Fenfluramine Or PlaceboNational Center For Research Resources1990–1993
  • MK-212 On Serum Cortisol, Prolactin And Growth HormoneNational Center For Research Resources1990–1993
  • Apomorphine On Serum Growth Hormone In Psychiatric PTS And Normal VolunteersNational Center For Research Resources1992
  • Bromocriptine Treatment Of Non-Delusional Major DepressionNational Institute Of Mental Health1990–1991
  • Treatment Of Tardive Dyskinesia In Schizophrenic Patients Receiving HaloperidolNational Institute Of Mental Health1987–1991
  • Serotonin In Depression, Mania, Suicide &The Action Of Thymoloptic DrugsNational Institute Of Mental Health1987–1991
  • Serotonergic Involvement Antidepressant Drug Action In An Animal ModelNational Institute Of Mental Health1987–1991
  • Platelet Monoamine OxidaseNational Institute Of Mental Health1987–1991
  • Plasma Tryptophan And 5-Hydroxyindoleascetic Acid Levels In DepressionNational Institute Of Mental Health1987–1991
  • Fluoxeting In The Treatment Of Major Depressive DisordersNational Institute Of Mental Health1987–1991
  • Effect Of L-Tryptophan And LI VS LI In Treatment Of Mania &SchizophreniaNational Institute Of Mental Health1987–1991
  • Effect Of Apomorphine On Plasma HVA And Serum PRL And GHNational Institute Of Mental Health1987–1991
  • Clozapine In Treatment-Resistant PatientsNational Institute Of Mental Health1987–1991
  • Chlorpromazine/Benztropine In Treatment-Resistant SchizophreniaNational Institute Of Mental Health1987–1991
  • Ritanserin On 5-Hydroxytryptophan-Induced Hormone Response In Psych. IllnessNational Center For Research Resources1990
  • Monamine Metabolites In Cerebrospinal Fluid In Psychiatric PatientsNational Center For Research Resources1990
  • Effect Of Buspirone On Hormonal Respones In Psychiatric IllnessNational Center For Research Resources1990
  • Depression--A Biological And Clinical AssessmentNational Center For Research Resources1990
  • Clonidine And Apomorphine On Serum Growth Hormone In Psychiatric PatientsNational Center For Research Resources1990
  • Bromocriptine Treatment Of Nm-Delusional Major DepressionNational Institute Of Mental Health1987–1989
  • Red Cell Adenosine Triphosphatase In PsychosesNational Institute Of Mental Health1985–1986
  • Prolactin, Neuroleptic Blood Levels And Clinical ResponseNational Institute Of Mental Health1985–1986
  • Platelet And Plasma MAONational Institute Of Mental Health1985–1986
  • Effect Of Psychotropic Drugs On Prolactin SecretionNational Institute Of Mental Health1985–1986
  • Effect Of Chlorpromazine On Serum Prolactin And Blood LevelsNational Institute Of Mental Health1985–1986
  • Effect Of Apomorphine On Growth Hormone And Prolactin In SchizophrenicsNational Institute Of Mental Health1985–1986
  • Development Of Radioimmunoassay For B-EndorphinNational Institute Of Mental Health1985–1986
  • Development Of Mhcrc Neuroendocrine LaboratoryNational Institute Of Mental Health1985–1986
  • Core Resource For Experimental Design, Statistics And Data AnalysisNational Institute Of Mental Health1985–1986
  • BiochemistryNational Institute Of Mental Health1985–1986
  • Response Of Psychiatric Patients To Neuroleptics And Dopamine AgonistsNational Center For Research Resources1985–1986

Hospital Affiliations